Nortriptyline for Idiopathic Gastroparesis - NCT00765895-94115 (Clinical Trial 244588)
Permalink: http://www.ClinicalConnection.com/exp/ExpandedPatientViewStudy244588.aspx
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
San Francisco |
|
State:
|
|
CA |
| Zip Code: |
|
94115 |
| Conditions: |
|
Idiopathic Gastroparesis |
| Purpose: |
|
The principal objective of this multicenter, randomized, placebo-controlled trial is to
evaluate whether treatment with nortriptyline will improve gastroparesis symptoms compared
with placebo.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Age 25 through 65 years old at registration
- Documentation of delayed gastric emptying on gastric emptying scintigraphy within 2
years of registration, defined as greater than 60% retention at 2 hours or greater
than 10% retention at 4 hours
- Symptoms of gastroparesis for at least 6 months (does not have to be contiguous)
prior to registration with Gastroparesis Cardinal Symptom Index (GCSI) score of 21 or
greater
- Negative upper endoscopy or upper GI series within 2 years of registration
Exclusion Criteria:
- Normal gastric emptying confirmed with scintigraphy
- Diabetic gastroparesis or post-surgical gastroparesis including fundoplication
- Another active disorder which could explain symptoms in the opinion of the
investigator
- History of significant cardiac arrhythmias and/or prolonged QTc
- History of seizures
- Use of narcotics more than 3 days per week
- Use of tricyclic antidepressants for refractory symptoms of gastroparesis within 6
weeks prior to randomization
- Use of strongly anticholinergic medications
- Use of calcium channel blockers
- Use of erythromycin
- Clear history of failed trial of nortriptyline use for gastroparetic symptoms
- Symptoms of primary depression or suicidal ideation
- Contraindications to nortriptyline:
1. hypersensitivity or allergy to any tricyclic antidepressant drug
2. concomitant therapy with a monoamine oxidase inhibitor (MAOI)
3. recent myocardial infarction
4. glaucoma
- Contraindications to gastric emptying breath test such as a known allergy to egg,
wheat, or algae
- Pregnancy or nursing
- Any other condition, which in the opinion of the investigator would impede compliance
or hinder completion of the study
- Use of a G tube, J tube, central catheter, or gastric electrical stimulator
- Failure to give informed consent |
|
|
|
| Study is available at: |
|
California Pacific Medical Center
San Francisco, CA 94115
United States
Primary Contact:
William Snape, MD
Email: snapew@sutterhealth.org
Phone: 415-516-9127
Secondary Contact:
James Tonascia, PhD
Email: jtonasci@jhsph.edu
Phone: 410-955-3704 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
November 16, 2009 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Clinical trials are medical research studies designed to test the safety and/or
effectiveness of new drugs, devices, or treatments in humans. These studies are
conducted worldwide for a range of conditions and illnesses. Learn more about
clinical research and participating in a study at
About Clinical Trials.
|
|
|
|
|